IQVIA Holdings Inc. (NYSE:IQV) Stock Holdings Boosted by Canada Pension Plan Investment Board

Canada Pension Plan Investment Board grew its holdings in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 20.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,282,024 shares of the medical research company's stock after purchasing an additional 712,958 shares during the quarter. IQVIA makes up approximately 0.8% of Canada Pension Plan Investment Board's portfolio, making the stock its 26th largest holding. Canada Pension Plan Investment Board owned 2.36% of IQVIA worth $841,461,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of IQV. Norges Bank acquired a new stake in shares of IQVIA during the 4th quarter worth about $336,041,000. Raymond James Financial Inc. purchased a new position in shares of IQVIA during the 4th quarter worth $236,120,000. American Century Companies Inc. increased its stake in IQVIA by 396.0% in the fourth quarter. American Century Companies Inc. now owns 1,134,737 shares of the medical research company's stock valued at $222,987,000 after purchasing an additional 905,960 shares during the last quarter. Invesco Ltd. lifted its position in IQVIA by 53.4% during the fourth quarter. Invesco Ltd. now owns 2,590,260 shares of the medical research company's stock worth $509,012,000 after buying an additional 902,226 shares during the period. Finally, JPMorgan Chase & Co. lifted its holdings in shares of IQVIA by 46.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,845,711 shares of the medical research company's stock worth $437,378,000 after acquiring an additional 583,396 shares during the period. 89.62% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on IQV shares. Royal Bank of Canada reaffirmed an "outperform" rating and set a $270.00 price target on shares of IQVIA in a research note on Monday, February 10th. BTIG Research lowered IQVIA from a "buy" rating to a "neutral" rating in a research note on Monday, February 3rd. Truist Financial reduced their price target on shares of IQVIA from $263.00 to $216.00 and set a "buy" rating on the stock in a research report on Thursday, April 10th. Barclays reaffirmed an "equal weight" rating and set a $170.00 price target (down from $235.00) on shares of IQVIA in a research report on Thursday, April 10th. Finally, Robert W. Baird lowered their target price on IQVIA from $212.00 to $210.00 and set a "neutral" rating for the company in a research note on Tuesday, January 21st. Six equities research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $241.50.

IQVIA Stock Performance

Shares of IQV stock traded up $2.19 during trading hours on Tuesday, reaching $143.41. The stock had a trading volume of 594,596 shares, compared to its average volume of 1,407,916. IQVIA Holdings Inc. has a twelve month low of $135.97 and a twelve month high of $252.88. The company has a debt-to-equity ratio of 2.12, a current ratio of 0.84 and a quick ratio of 0.84. The firm has a market capitalization of $25.28 billion, a PE ratio of 19.14, a price-to-earnings-growth ratio of 1.99 and a beta of 1.46. The firm has a 50-day simple moving average of $175.30 and a 200-day simple moving average of $195.79.

IQVIA (NYSE:IQV - Get Free Report) last announced its earnings results on Thursday, February 6th. The medical research company reported $2.90 earnings per share for the quarter, missing the consensus estimate of $3.11 by ($0.21). IQVIA had a net margin of 8.91% and a return on equity of 28.81%. As a group, equities analysts forecast that IQVIA Holdings Inc. will post 10.84 earnings per share for the current year.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.